Evidence map›Paper›PMID 32833579›Full record

ArticleOmics : a journal of integrative biology2020

Glycomics: Immunoglobulin G

Zixiu Meng, Cancan Li, Guoyong Ding, Weijie Cao, Xizhu Xu, Yuanyuan Heng, Yang Deng, Yuejin Li, Xiaoyu Zhang, Dong Li and 4 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Omics : a journal of integrative biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Zixiu MengSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Cancan LiSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Guoyong DingSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Weijie CaoBeijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.
Xizhu XuSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Yuanyuan HengSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Yang DengSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Yuejin LiSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Xiaoyu ZhangBeijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China.
Dong LiSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Wei WangSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Youxin WangSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Weijia XingSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Haifeng HouSchool of Public Health, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Shandong First Medical University · CNCapital Medical University · CNEdith Cowan University · AUBinzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mammary gland hyperplasia (MGH) is very common, especially among young and middle-aged women. New diagnostics and biomarkers for MGH are needed for rational clinical management and precision medicine. We report, in this study, new findings using a glycomics approach, with a focus on immunoglobulin G (IgG)

Indexed as

GlycomicsAdultAgedBiomarkersChinaChromatography, High Pressure LiquidCross-Sectional StudiesFemaleGlycoproteinsGlycosylationHumansHyperplasiaImmunoglobulin GMammary Glands, HumanMiddle AgedPolysaccharidesBiomarkersGlycoproteinsglycosylated IgGImmunoglobulin GPolysaccharidesbiomarkersbreast dysplasiaglycomicsglycosylationimmunoglobulin Gmammary gland hyperplasia

Identifiers

PMID32833579
PMCPMC7480711
OpenAlexW3095422019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.